These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

294 related items for PubMed ID: 17560012

  • 1. Global proteome profiling of NPM/ALK-positive anaplastic large cell lymphoma.
    Sjostrom C, Seiler C, Crockett DK, Tripp SR, Elenitoba Johnson KS, Lim MS.
    Exp Hematol; 2007 Aug; 35(8):1240-8. PubMed ID: 17560012
    [Abstract] [Full Text] [Related]

  • 2. Analysis of gene expression profile of TPM3-ALK positive anaplastic large cell lymphoma reveals overlapping and unique patterns with that of NPM-ALK positive anaplastic large cell lymphoma.
    Bohling SD, Jenson SD, Crockett DK, Schumacher JA, Elenitoba-Johnson KS, Lim MS.
    Leuk Res; 2008 Mar; 32(3):383-93. PubMed ID: 17720243
    [Abstract] [Full Text] [Related]

  • 3. Identification of NPM-ALK interacting proteins by tandem mass spectrometry.
    Crockett DK, Lin Z, Elenitoba-Johnson KS, Lim MS.
    Oncogene; 2004 Apr 08; 23(15):2617-29. PubMed ID: 14968112
    [Abstract] [Full Text] [Related]

  • 4. The expression of CD30 in anaplastic large cell lymphoma is regulated by nucleophosmin-anaplastic lymphoma kinase-mediated JunB level in a cell type-specific manner.
    Hsu FY, Johnston PB, Burke KA, Zhao Y.
    Cancer Res; 2006 Sep 15; 66(18):9002-8. PubMed ID: 16982741
    [Abstract] [Full Text] [Related]

  • 5. Downregulation of NPM-ALK by siRNA causes anaplastic large cell lymphoma cell growth inhibition and augments the anti cancer effects of chemotherapy in vitro.
    Hsu FY, Zhao Y, Anderson WF, Johnston PB.
    Cancer Invest; 2007 Jun 15; 25(4):240-8. PubMed ID: 17612934
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Mapping of genomic t(2;5)(p23;q35) break points in patients with anaplastic large cell lymphoma by sequencing long-range PCR products.
    Luthra R, Pugh WC, Waasdorp M, Morris W, Cabanillas F, Chan PK, Sarris AH.
    Hematopathol Mol Hematol; 1998 Jun 15; 11(3-4):173-83. PubMed ID: 9844824
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Selective inhibition of STAT3 induces apoptosis and G(1) cell cycle arrest in ALK-positive anaplastic large cell lymphoma.
    Amin HM, McDonnell TJ, Ma Y, Lin Q, Fujio Y, Kunisada K, Leventaki V, Das P, Rassidakis GZ, Cutler C, Medeiros LJ, Lai R.
    Oncogene; 2004 Jul 15; 23(32):5426-34. PubMed ID: 15184887
    [Abstract] [Full Text] [Related]

  • 11. Pathobiology of NPM-ALK and variant fusion genes in anaplastic large cell lymphoma and other lymphomas.
    Drexler HG, Gignac SM, von Wasielewski R, Werner M, Dirks WG.
    Leukemia; 2000 Sep 15; 14(9):1533-59. PubMed ID: 10994999
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Differential expression of cyclin D3 in ALK+ and ALK- anaplastic large cell lymphoma.
    Dalton RR, Rassidakis GZ, Atwell C, Wang S, Oyarzo MP, Medeiros LJ.
    Hum Pathol; 2005 Jul 15; 36(7):806-11. PubMed ID: 16084951
    [Abstract] [Full Text] [Related]

  • 14. Differential expression and clinical significance of tyrosine-phosphorylated STAT3 in ALK+ and ALK- anaplastic large cell lymphoma.
    Khoury JD, Medeiros LJ, Rassidakis GZ, Yared MA, Tsioli P, Leventaki V, Schmitt-Graeff A, Herling M, Amin HM, Lai R.
    Clin Cancer Res; 2003 Sep 01; 9(10 Pt 1):3692-9. PubMed ID: 14506160
    [Abstract] [Full Text] [Related]

  • 15. The NPM/ALK gene fusion in the pathogenesis of anaplastic large cell lymphoma.
    Ladanyi M.
    Cancer Surv; 1997 Sep 01; 30():59-75. PubMed ID: 9547986
    [Abstract] [Full Text] [Related]

  • 16. Differential expression of BCL-2 family proteins in ALK-positive and ALK-negative anaplastic large cell lymphoma of T/null-cell lineage.
    Rassidakis GZ, Sarris AH, Herling M, Ford RJ, Cabanillas F, McDonnell TJ, Medeiros LJ.
    Am J Pathol; 2001 Aug 01; 159(2):527-35. PubMed ID: 11485911
    [Abstract] [Full Text] [Related]

  • 17. Signal transducer and activator of transcription-3 activation contributes to high tissue inhibitor of metalloproteinase-1 expression in anaplastic lymphoma kinase-positive anaplastic large cell lymphoma.
    Lai R, Rassidakis GZ, Medeiros LJ, Ramdas L, Goy AH, Cutler C, Fujio Y, Kunisada K, Amin HM, Gilles F.
    Am J Pathol; 2004 Jun 01; 164(6):2251-8. PubMed ID: 15161657
    [Abstract] [Full Text] [Related]

  • 18. JunB induced by constitutive CD30-extracellular signal-regulated kinase 1/2 mitogen-activated protein kinase signaling activates the CD30 promoter in anaplastic large cell lymphoma and reed-sternberg cells of Hodgkin lymphoma.
    Watanabe M, Sasaki M, Itoh K, Higashihara M, Umezawa K, Kadin ME, Abraham LJ, Watanabe T, Horie R.
    Cancer Res; 2005 Sep 01; 65(17):7628-34. PubMed ID: 16140928
    [Abstract] [Full Text] [Related]

  • 19. The tyrosine phosphatase Shp2 interacts with NPM-ALK and regulates anaplastic lymphoma cell growth and migration.
    Voena C, Conte C, Ambrogio C, Boeri Erba E, Boccalatte F, Mohammed S, Jensen ON, Palestro G, Inghirami G, Chiarle R.
    Cancer Res; 2007 May 01; 67(9):4278-86. PubMed ID: 17483340
    [Abstract] [Full Text] [Related]

  • 20. Biochemical detection of novel anaplastic lymphoma kinase proteins in tissue sections of anaplastic large cell lymphoma.
    Pulford K, Falini B, Cordell J, Rosenwald A, Ott G, Müller-Hermelink HK, MacLennan KA, Lamant L, Carbone A, Campo E, Mason DY.
    Am J Pathol; 1999 Jun 01; 154(6):1657-63. PubMed ID: 10362790
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.